Follow The Filings

ONC Beone Medicines Ltd.

Health Care, filed as BEONE MEDICINES LTD (SPONSORED ADS), Equity As of 2026 Q2 among managers we track Quote on Google Finance, opens in a new tab

  • 1 exit

In 2026 Q2 Farallon Capital Management sold out of Beone Medicines.

Who owns ONC

Sorted by value, long equity only, as of 2026 Q2.

History
Farallon Capital Management exited 2026 Q2 Last 2026 Q1 <0.01% Exit 0.00% 1,100 $327K History

0 current, 1 exited last period, options excluded

Insider trades

Open-market buys and sales by ONC's executives, directors and 10% owners in the last 12 months, from their Form 4s

All ONC insider trades
  • None no insider bought on the open market
  • $16.5M sold by 11 insiders outside a trading plan
  • $375M sold by 4 insiders under 10b5-1 plans
  1. Xiaodong Wang Director
    Planned sale
    $11.3M 31,028 shares at $362.97 100% of stake
    Traded Oct 27 Filed Oct 29
    ↗
  2. Xiaodong Wang Director
    Planned sale
    $10.9M 31,027 shares at $350.99 100% of stake
    Traded Oct 13 Filed Oct 15
    ↗
  3. Chan Henry Lee SVP, General Counsel
    Planned sale
    $418K 1,115 shares at $375.00 100% of stake
    Traded Sep 30 Filed Oct 2
    ↗
  4. Xiaodong Wang Director
    Planned sale
    $11.3M 31,028 shares at $364.79 100% of stake
    Traded Sep 28 Filed Sep 30
    ↗
  5. Xiaodong Wang Director
    Planned sale
    $13.4M 38,287 shares at $349.10 100% of stake
    Traded Sep 8 Filed Sep 10
    ↗
  6. Titus B. Ball Principal Accounting Officer
    Sale
    $47K 132 shares at $355.86 100% of stake
    Traded Sep 1 Filed Sep 3
    ↗
  7. Xiaobin Wu COO
    Planned sale
    $106K 280 shares at $380.00 100% of stake
    Traded Aug 25 Filed Aug 27
    ↗
  8. Chan Henry Lee SVP, General Counsel
    Planned sale
    $960K 2,666 shares at $360.00 100% of stake
    Traded Aug 11 Filed Aug 13
    ↗
  9. John Oyler CEO
    Planned sale
    $86.5M 240,810 shares at $359.12 100% of stake
    Traded Aug 10–12 Filed Aug 12
    ↗
  10. Aaron Rosenberg CFO
    Sale
    $362K 1,157 shares at $312.72 100% of stake
    Traded Aug 3 Filed Aug 5
    ↗
  11. Chan Henry Lee SVP, General Counsel
    Sale
    $338K 1,044 shares at $323.69 100% of stake
    Traded Jul 30 Filed Aug 3
    ↗
  12. Chan Henry Lee SVP, General Counsel
    Planned sale
    $542K 1,669 shares at $325.00 100% of stake
    Traded Jul 22 Filed Jul 24
    ↗
  13. John Oyler CEO
    Planned sale
    $34.6M 109,713 shares at $315.28 100% of stake
    Traded Jul 20–21 Filed Jul 22
    ↗
  14. John Oyler CEO
    Planned sale
    $20.2M 64,628 shares at $312.00 100% of stake
    Traded Jul 17 Filed Jul 17
    ↗
  15. John Oyler CEO
    Planned sale
    $89.4M 283,154 shares at $315.56 100% of stake
    Traded Jul 15–16 Filed Jul 17
    ↗

Also filed in the last 12 months, not counted as buying or selling: 51 option exercises, 27 stock grants, and 3 gifts.

SEC filings

Recent issuer filings from EDGAR, 5 shown.

Filed Form Detail Links
SCHEDULE 13D/A — Filing Doc
8-K 2.02,9.01 Filing Doc
8-K 2.02,9.01 Filing Doc
10-Q Filing Doc
8-K 8.01 Filing Doc

Source: SEC EDGAR submissions, updated 3 days ago. All on EDGAR

Financials

US-GAAP annual figures by fiscal year, as tagged in Form 10-K. Each value links to its SEC filing.

Income statement

Metric FY2023 FY2024 FY2025
Revenue $2.46B $3.81B $5.34B
Gross profit $2.08B $3.22B $4.67B
Gross margin * 84.5% 84.4% 87.5%
Net income -$881.71M -$644.79M $286.93M
Net margin * -35.9% -16.9% 5.4%

Balance sheet

Metric FY2023 FY2024 FY2025
Total current assets $4.2B $3.99B $6.23B
Total non-current assets $1.6B $1.93B $1.95B
Total assets $5.81B $5.92B $8.19B
Total current liabilities $1.81B $2.21B $1.83B
Total non-current liabilities $0.458B $0.374B $2B
Total equity $3.54B $3.33B $4.36B

Cash flow

Metric FY2023 FY2024 FY2025
Cash from operations -$1.16B -$0.141B $1.13B
Cash from investing $60M -$548.35M -$276.16M
Cash from financing $0.416B $0.193B $1.06B
Net change in cash -$0.689B -$0.547B $1.97B

Source: SEC companyfacts (US-GAAP 10-K). A * marks a computed figure, not a single XBRL tag. Fiscal years are as the issuer labels them. Follow The Filings does not adjust or audit these figures.

Ownership over time

13Fs that reported it each quarter. Click a bar for that quarter’s holders.

Further reading

As an Amazon Associate, FollowTheFilings earns from qualifying purchases.

More on the shelf